CLINICAL TRIALS PROFILE FOR MURAGLITAZAR
✉ Email this page to a colleague
Clinical Trials for Muraglitazar
Trial ID | Title | Status | Sponsor | Phase | Summary |
---|---|---|---|---|---|
NCT00094991 ↗ | Mechanism of Action and Efficacy of Muraglitazar in Type 2 Diabetes | Completed | Merck Sharp & Dohme Corp. | Phase 3 | The purpose of this study is to learn more about how muraglitazar lowers blood sugar in people with type 2 diabetes. The safety of this treatment will also be studied. |
NCT00094991 ↗ | Mechanism of Action and Efficacy of Muraglitazar in Type 2 Diabetes | Completed | Bristol-Myers Squibb | Phase 3 | The purpose of this study is to learn more about how muraglitazar lowers blood sugar in people with type 2 diabetes. The safety of this treatment will also be studied. |
NCT00095030 ↗ | Study Comparing Muraglitazar With Glimepiride in Type 2 Diabetics Who Are Not Controlled With Metformin Alone | Completed | Merck Sharp & Dohme Corp. | Phase 3 | The purpose of this clinical research study is to learn whether a muraglitazar-metformin combination is at least as effective as a glimepiride-metformin combination to treat type 2 diabetics who are not sufficiently controlled with metformin alone. The safety of this treatment will also be studied. |
NCT00095030 ↗ | Study Comparing Muraglitazar With Glimepiride in Type 2 Diabetics Who Are Not Controlled With Metformin Alone | Completed | Bristol-Myers Squibb | Phase 3 | The purpose of this clinical research study is to learn whether a muraglitazar-metformin combination is at least as effective as a glimepiride-metformin combination to treat type 2 diabetics who are not sufficiently controlled with metformin alone. The safety of this treatment will also be studied. |
NCT00106808 ↗ | Study of Muraglitazar Versus Pioglitazone in Type 2 Diabetes | Completed | Merck Sharp & Dohme Corp. | Phase 3 | The purpose of this study is to compare Muraglitazar and Pioglitazone in patients with Type 2 Diabetes. Both the safety and blood sugar lowering effects of these treatments will be studied. |
NCT00106808 ↗ | Study of Muraglitazar Versus Pioglitazone in Type 2 Diabetes | Completed | Bristol-Myers Squibb | Phase 3 | The purpose of this study is to compare Muraglitazar and Pioglitazone in patients with Type 2 Diabetes. Both the safety and blood sugar lowering effects of these treatments will be studied. |
NCT00130806 ↗ | An Investigational Drug Co-Administered With Insulin in Patients With Type 2 Diabetes (0478-065) | Terminated | Bristol-Myers Squibb | Phase 3 | This is a study to evaluate the effectiveness and tolerability of an investigational drug in patients with type 2 diabetes (a specific type of diabetes) who are not currently treated with insulin. |
>Trial ID | >Title | >Status | >Sponsor | >Phase | >Summary |
Clinical Trial Conditions for Muraglitazar
Condition Name
Clinical Trial Locations for Muraglitazar
Trials by Country
Clinical Trial Progress for Muraglitazar
Clinical Trial Phase
Clinical Trial Sponsors for Muraglitazar
Sponsor Name